Research Use Only. The information presented here is for scientific and educational purposes. These compounds are not intended for human consumption, self-administration, or therapeutic use.
Introduction
Among the peptides to emerge from Soviet and Russian neuropharmacology, Semax and Selank occupy a distinctive niche. Both are synthetic heptapeptides engineered from naturally occurring regulatory sequences, and both have been investigated in preclinical and in-vitro models for their influence on the central nervous system. Semax is a synthetic fragment analog of adrenocorticotropic hormone (ACTH 4-10), while Selank is a synthetic analog of the endogenous immunomodulatory peptide tuftsin. Despite their shared heptapeptide architecture, the two molecules are studied along notably different signaling pathways.
This comparison examines Semax vs Selank from a laboratory perspective: their molecular identities, the neurochemical mechanisms reported in published research, and the distinct experimental questions each compound has been used to probe. Semax has drawn attention in studies of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expression, whereas Selank has been examined in the context of GABAergic and serotonergic modulation and anxiety-like behavior in rodent models. All discussion here is provided for research use only, not for human consumption.
Molecular Identity and Origins
Although Semax and Selank are frequently grouped together as “Russian nootropic peptides,” their structural origins are unrelated. Both are associated with work at the Institute of Molecular Genetics of the Russian Academy of Sciences, and each was designed using the same stabilization strategy: appending a Pro-Gly-Pro tripeptide tail to a shorter biologically active sequence. That modification is intended to slow enzymatic degradation and extend the molecule’s stability in experimental preparations.
Semax: An ACTH-Derived Fragment
Semax corresponds to the sequence Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP). Its N-terminal portion mirrors the ACTH(4-7) fragment, a region of adrenocorticotropic hormone associated in the literature with neurotropic and behavioral properties that are independent of the hormone’s corticotropic (steroidogenic) activity. By adding the Pro-Gly-Pro extension, researchers produced a compound reported to resist rapid breakdown while retaining the neuroactive character of the parent fragment.
Selank: A Tuftsin Analog
Selank is built on the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Its active core derives from tuftsin, a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg) with documented immunomodulatory roles. The same Pro-Gly-Pro tail confers stability. This tuftsin lineage is why Selank appears in research literature addressing not only behavior but also immune signaling and interferon-related pathways.
The values below reflect commonly reported laboratory attributes and are provided for comparison only.
| Attribute | Semax | Selank |
|---|---|---|
| Amino acid sequence | Met-Glu-His-Phe-Pro-Gly-Pro | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Sequence length | 7 residues (heptapeptide) | 7 residues (heptapeptide) |
| Molecular formula | C37H51N9O10S | C33H57N11O9 |
| Approximate molecular weight | ~813.9 g/mol | ~751.9 g/mol |
| Parent sequence | ACTH(4-7) fragment | Tuftsin (Thr-Lys-Pro-Arg) |
| Peptide class | ACTH-analog neuropeptide | Tuftsin-analog neuropeptide |
Mechanistic Pathways Compared
The clearest way to distinguish these two research peptides is by the signaling systems each has been reported to engage. There is some overlap, since both have been associated with changes in BDNF expression in certain models, but their primary mechanistic footprints differ.
Semax and Neurotrophic Signaling
Published preclinical work has examined Semax for its apparent capacity to upregulate BDNF and NGF along with their receptor systems in hippocampal tissue. Investigations in rodent cerebral ischemia models have used Semax as a probe for neuroprotective signaling, and several studies report modulation of dopaminergic and serotonergic activity. Because of its ACTH-derived structure, Semax has also prompted research into melanocortin-adjacent signaling, though without the corticotropic action of the full-length hormone.
Selank and Anxiolytic-Related Pathways
Selank has most frequently been investigated in animal models of anxiety-like behavior. Research literature attributes its effects in these paradigms to modulation of the GABAergic system and to changes in the expression and metabolism of enkephalins, including inhibition of enkephalin-degrading enzymes. As a tuftsin analog, Selank has additionally been studied for effects on the balance of pro- and anti-inflammatory cytokines and on interferon induction, connecting its behavioral research to its immunological lineage.
Research Applications and Distinctions
Because their mechanisms diverge, Semax and Selank tend to appear in different categories of experimental design. The overview below summarizes how each compound is typically framed in the literature. These values reflect commonly reported laboratory attributes and are provided for comparison only.
| Research dimension | Semax | Selank |
|---|---|---|
| Primary studied pathway | BDNF and NGF neurotrophic signaling | GABAergic and enkephalin modulation |
| Common model systems | Cerebral ischemia, cognition and attention paradigms | Anxiety-like behavior paradigms |
| Secondary research interest | Dopaminergic and serotonergic modulation, neuroprotection | Cytokine balance and interferon induction (tuftsin lineage) |
| Structural lineage | ACTH(4-7) fragment | Tuftsin tetrapeptide |
| Typical research format | Lyophilized powder | Lyophilized powder |
Why They Are Studied Side by Side
Some protocols examine the two peptides in parallel precisely because they share the stabilized heptapeptide format and comparable physicochemical properties used in intranasal animal studies. That common design makes each a convenient reference point for the other: contrasting a neurotrophic-focused compound against an anxiolytic-focused one within a single structural family. Both nonetheless remain firmly within the research use only category. For a broader view of related molecules, the Rejuven8 research peptide catalog groups nootropic-adjacent compounds for comparison.
Laboratory Handling and Sourcing Considerations
Both peptides are supplied as lyophilized (freeze-dried) powder that requires reconstitution before use in a research setting. Because they are short peptides, they are typically dissolved in bacteriostatic water, kept cold, and handled so that freeze-thaw cycles are minimized to preserve peptide integrity. For a full treatment of solvent selection and reconstitution mechanics, see the bacteriostatic water reconstitution guide. As a single worked example, reconstituting a 10 mg vial with 2 mL of bacteriostatic water yields a concentration of 5 mg/mL.
Purity and Documentation
Peptide identity and purity should be confirmed against a certificate of analysis before any experimental work. Interpreting those documents (mass spectrometry identity confirmation and HPLC purity percentage) is covered in the COA reading guide, and choosing a documented, lab-tested vendor is discussed in the supplier vetting guide. Research-grade Semax and Selank should always carry this supporting analytical documentation so that reported sequence, molecular weight, and purity can be verified against the batch in hand.
Frequently Asked Questions
What is the difference between Semax and Selank?
Semax and Selank are both synthetic heptapeptides studied in Russian neuropharmacology, but they derive from different parent molecules and engage different pathways. Semax is an ACTH(4-7) fragment analog investigated primarily for BDNF and NGF neurotrophic signaling, while Selank is a tuftsin analog studied mainly for GABAergic modulation and anxiety-like behavior in animal models. That mechanistic contrast is the core of any semax vs selank comparison.
Are Semax and Selank the same class of peptide?
They share a structural format, since both are seven-amino-acid peptides stabilized with a Pro-Gly-Pro tail, but they belong to different lineages. Semax is classed as an ACTH-analog neuropeptide, whereas Selank is a tuftsin-analog neuropeptide with additional immunomodulatory research context.
What is the molecular weight of Semax and Selank?
Semax has an approximate molecular weight of 813.9 g/mol (molecular formula C37H51N9O10S), and Selank is approximately 751.9 g/mol (molecular formula C33H57N11O9). Both figures reflect commonly reported laboratory values and are provided for comparison only.
Why are Semax and Selank often studied together?
Researchers frequently discuss the two side by side because they emerged from the same research tradition, share the stabilized heptapeptide design, and are both examined for central nervous system effects. Their contrasting mechanisms make them useful reference points for one another in comparative preclinical study.
Can Semax and Selank be used in humans?
No. Both compounds are offered strictly for research use only and are not intended for human consumption, self-administration, or therapeutic use. All data referenced here derives from preclinical, in-vitro, or animal studies.
How are Semax and Selank stored and reconstituted in research settings?
As lyophilized powders, both are typically reconstituted with bacteriostatic water, stored cold, and protected from repeated freeze-thaw cycles. Detailed procedures are covered in the bacteriostatic water reconstitution guide linked above.
References and Further Reading
- PubMed: semax BDNF. Preclinical investigations of Semax and its reported influence on brain-derived neurotrophic factor expression in neural tissue.
- PubMed: semax cerebral ischemia. Animal-model research using Semax as a probe for neuroprotective signaling in cerebral ischemia paradigms.
- PubMed: semax ACTH fragment. Studies on the ACTH(4-10) and ACTH(4-7) fragment origins of Semax and their neurotropic properties.
- PubMed: selank anxiolytic. Rodent-model research examining Selank in anxiety-like behavior paradigms.
- PubMed: selank GABA. Literature addressing Selank and modulation of the GABAergic system.
- PubMed: selank tuftsin. Research on the tuftsin lineage of Selank and its associated immunomodulatory and interferon-related signaling.
- PubMed: semax selank peptide. Comparative and review discussion of Semax and Selank as stabilized regulatory heptapeptides.
